Scar Formation with Decreased Cardiac Function Following Ischemia/Reperfusion Injury in 1 Month Old Swine.
Agnew, EJ; Velayutham, N; Ortiz, GM; Alfieri, CM; Hortells, L; Moore, V; Riggs, KW; Baker, RS; Gibson, AM; Ponny, SR; et al.
Journal of Cardiovascular Development and Disease.
2020;
7:1-1.
Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim, AJ; Xu, N; Umeyama, K; Hulin, A; Ponny, SR; Vagnozzi, RJ; Green, EA; Hanson, P; McManus, BM; Nagashima, H; et al.
Circulation.
2020;
141:132-146.
Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.
Gomez-Stallons, MV; Tretter, JT; Hassel, K; Gonzalez-Ramos, O; Amofa, D; Ollberding, NJ; Mazur, W; Choo, JK; Smith, JM; Kereiakes, DJ; et al.
Heart.
2019;
105:1616-1621.
Postnatal Cardiac Development and Regenerative Potential in Large Mammals.
Velayutham, N; Agnew, EJ; Yutzey, KE.
Pediatric Cardiology.
2019;
40:1345-1358.
Cardiac fibroblasts and the extracellular matrix in regenerative and nonregenerative hearts.
Hortells, L; Johansen, AK Z; Yutzey, KE.
Journal of Cardiovascular Development and Disease.
2019;
6:29-29.
Maturation of heart valve cell populations during postnatal remodeling.
Hulin, A; Hortells, L; Gomez-Stallons, MV; O'Donnell, A; Chetal, K; Adam, M; Lancellotti, P; Oury, C; Potter, SS; Salomonis, N; et al.
Development (Cambridge).
2019;
146:dev173047-dev173047.
Endothelial Cell Lineage Analysis Does Not Provide Evidence for EMT in Adult Valve Homeostasis and Disease.
Kim, AJ; Alfieri, CM; Yutzey, KE.
The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology.
2019;
302:125-135.
Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease.
Hulin, A; Anstine, LJ; Kim, AJ; Potter, SJ; DeFalco, T; Lincoln, J; Yutzey, KE.
Arteriosclerosis, Thrombosis, and Vascular Biology.
2018;
38:636-644.
Loss of beta-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice.
Xiang, F; Fang, M; Yutzey, KE.
Nature Communications.
2017;
8.
Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin, A; Moore, V; James, JM; Yutzey, KE.
Cardiovascular Research.
2017;
113:40-51.